High liver fat fraction in CCTA helps diagnose major adverse cardiovascular events in T2DM patients: Study
A new study published in the journal of BMC Cardiovascular Diabetelogy showed that an elevated liver fat fraction (LFF) on coronary CT angiography (CCTA) imaging seems to be a separate predictor of major adverse cardiovascular events (MACE) in individuals with type 2 diabetes.
Numerous microvascular and macrovascular problems are brought on by type 2 diabetes mellitus (T2DM). Among people with type 2 diabetes, cardiovascular illnesses are the primary cause of death. Therefore, it is crucial to accurately predict major adverse cardiovascular events in patients with T2DM to enable timely therapeutic intervention in the management of cardiovascular problems in these patients. This study was set to investigate the incremental predictive value of liver fat fraction in predicting MACE in individuals with T2DM.
A total of 265 T2DM patients who arrived at our hospital between August 2021 and August 2022 with chest discomfort and distress indicative of coronary artery disease (CAD) were prospectively recruited in this study. Within a 7-day period, all individuals had upper abdomen dual-layer spectral detector computed tomography (SDCT) and CCTA.
Carefully documented were the LFF ascertained by the SDCT multi-material breakdown technique, CCTA imaging characteristics, and detailed clinical data. MACE was defined as the incidence of late-phase coronary revascularization operations, acute coronary syndrome (ACS), cardiac mortality, and heart failure-related hospitalizations.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.